MannKind Corporation (MNKD) News: FDA Approval, Cloud Hosting & More

With luck, Santa Clarita’s MannKind Corporation (NASDAQ:MNKD) hopes to have FDA approval by April of next year of its innovative diabetes treatment – Afrezza.

Keep Reading →